INVESTIGATION OF FACTORS RELATING TO THE CHANGE OF CYCLE THRESHOLD (CT) INDEX IN RT-PCR TESTING AMONG COVID-19 PATIENTS, AT THE MILITARY HOSPITAL 7
Tóm tắt
Purpose: We aimed to evaluate some factors related to changes of CT values in RT-PCR testing among patients infected with COVID-19 treated at Military Hosptial 7, Military Zone 3. This contributes to diagnosis and prognosis of disease.
Methods: Prospective and cross-sectional descriptive study.
Results: The mean age of the patients was 40.06 ± 14.34 years. 80.46% were males. 97.39% of the patients were vaccinated against COVID-19. 60.58% of them experienced post-COVID-19 syndrome.
- On day 5 of COVID-19, the significantly lower CT values found in individuals reporting receipt less than 3 doses with respect to those who received completely 3 doses of COVID-19 vaccines (OR = 1.59; p < 0.05). Patients developing post-COVID-19 syndrome had a lower CT value than those without manifestations of this syndrome (OR = 1.73; p < 0.05); subjects treated with antiretroviral drugs (ARV) had a higher CT value than those nontreated (with OR = 5.06; p < 0.001).
- On day 10 of COVID-19, subjects without antiretroviral drugs (ARV) use had a lower CT values than those on antiretroviral medications (OR = 3.91; p < 0.001).
Tài liệu tham khảo
Ministry of Health (2022), Guidelines for the Diagnosis and Treatment of COVID-19, Decision No. 250/QD-BYT, 28/1/2022 of Minister of Health
Ministry of Health (2022), Medical examination and treatment for people have COVID-19 infection, Documentary No. 2055/ BYT-KCB, 22/4/2022 of Minister of Health
Hoang Van Hung and partner (2021), “Clinical characteristics and a severity score of lung injury on chest radiography in hospitalized patients with COVID-19”“, Vietnam Medical Journal, 505 (1), 134-137.
Hoang Van Ly and partner (2022), “Study on some clinical, laboratory characteristics of 1,168 COVID-19 patients treated at Infectious Field Hospital 5D”, Journal of Military Medicine, 356, 2-6.
Le Tien Dung and partner (2021), “Evaluating the clinical, paraclinical characteristics of COVID-19 with background disease , treated at Infectious Field Hospital 2”, Journal of Military Pharmaco-medicine (2021), 162-167.
Guan W.J, Ni Z.Y et al, (2020), “Clinical characteristics of Coronavirus disease 2019 in China”, N Engl J Med, vol.382, no.18, pp. 1708-1720.
Singanayagam A, Patel M, Charlett A, et al (2020), “Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19”, Eurosurveillance.
Peghin M, Palese A, Venturini M, et al (2021), “Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients”, Clin Microbiol Infect, pp. 1507-1513.
Gal-Oz S.T., Maier B. and Yoshida H. (2019). “ImmGen report: sexual dimorphism in the immune system transcriptome”, J Nat Commun, vol. 10, no. 1, pp. 4292.
Foulkes A.S, Selvaggi C, Shinnick D et al (2021), “Understanding the link between obesity and severe COVID-19 outcomes: Causal mediation by systemic inflammatory response”, The Journal of clinical endocrinology and metabolism.
Soriano J.B, Waterer G, Peñalvo J.L, Rello J (2021), “Nefer, Sinuhe and clinical research assessing post COVID-19 condition”, European Respiratory Journal, 57, 2004423. 10.1183 /13993003.04423-2020.
Joo E.J, Ko J.H, Kim S.E, et al (2021), “Clinical and virologic effectiveness of Remdesivir treatment for severe COVID-19 in Korea: a nationwide multicenter retrospective cohort study”, J Korean Med Sci, p.36(11): e83.
Tải xuống
Đã Xuất bản
Cách trích dẫn
Số
Chuyên mục
Ngày xuất bản 04-05-2023
